Andere Kunden interessierten sich auch für
![Targeting the Microbiome for Disease Diagnosis and Therapy]( "Targeting the Microbiome for Disease Diagnosis and Therapy")
Targeting the Microbiome for Disease Diagnosis and Therapy92,99 €![Advances in Preterm Delivery]( "Advances in Preterm Delivery")
Advances in Preterm Delivery67,99 €![Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research]( "Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research")
Classification of Lymphomas and Hematological Neoplasia in the Era of Genomic Research94,99 €![The Digestive System in the Era of COVID-19]( "The Digestive System in the Era of COVID-19")
The Digestive System in the Era of COVID-1964,99 €![Primary Mental Health Care in a New Era]( "Primary Mental Health Care in a New Era")
Primary Mental Health Care in a New Era75,99 €![Dietary Plant Origin Bio-Active Compounds, Intestinal Functionality and Microbiome]( "Dietary Plant Origin Bio-Active Compounds, Intestinal Functionality and Microbiome")
Dietary Plant Origin Bio-Active Compounds, Intestinal Functionality and Microbiome72,99 €![The Human Microbiome]( "The Human Microbiome")
The Human Microbiome102,99 €
We have entered a new era where some concepts of the complex community of microorganisms (microbiota comprising bacteria, fungi, viruses, bacteriophages and helminths) are being re-discovered and re-visited. Microbiota and human interaction is not new; they have shared a long history of co-existence. Nevertheless, the opportunities to understand the role of these microorganisms in human diseases and to design a potential treatment were limited. At present, thanks to development of innovative and cutting-edge molecular biological and microbiological technologies as well as clinical informatics and bioinformatics skills, microbiome application is moving into clinics. Approaches to therapy based on prebiotics, probiotics and lately on fecal microbiota transplantation has revolutionized medicine. Microbiota outnumbers our genes and is now regarded as another organ of the body. The gastrointestinal tract and gut microbiota display a well-documented symbiotic relationship. Disruption of intestinal microbiota homeostasis-called dysbiosis-has been associated with several diseases. Whether dysbiosis is a cause or consequence of disease initiation and progression still needs to be investigated in more depth. The aim of this book is to highlight recent advances in the field of microbiome research, which are now shaping medicine, and current approaches to microbiome-oriented therapy for gastrointestinal diseases. Dr. Rinaldo Pellicano Dr. Sharmila Fagoonee&